Preventing memory loss is possible. Neurotrack uses clinically proven science to help you assess and improve your memory over time.
Neurotrack is an innovative digital health company on a mission to transform the assessment and prevention of memory loss and related diseases like Alzheimer’s. Founded in 2012, Neurotrack has successfully built and is deploying the first validated predictive diagnostic test for cognitive decline that can identify an individual’s risk for the disease as early as six years before symptoms. Based in Palo Alto, Neurotrack has raised funding from Sozo Ventures, Marc Benioff, Khosla Ventures, Founders Fund, Social Capital, AME Cloud Partners and Rethink Impact.